Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts

Схожие документы

• Promising Therapeutic Efficacy of GC1118, an Anti-EGFR Antibody, against KRAS Mutation-Driven Colorectal Cancer Patient-Derived Xenografts
  по: Lee, Hye Won, et al.
  Опубликовано: (2019)
• A target‐mediated drug disposition population pharmacokinetic model of GC1118, a novel anti‐EGFR antibody, in patients with solid tumors
  по: Chung, Tae Kyu, et al.
  Опубликовано: (2021)
• Novel Semi-Replicative Retroviral Vector Mediated Double Suicide Gene Transfer Enhances Antitumor Effects in Patient-Derived Glioblastoma Models
  по: Lee, Mijeong, et al.
  Опубликовано: (2019)
• Optimization of PCR Conditions for Amplification of GC‐Rich EGFR Promoter Sequence
  по: Obradovic, Jasmina, et al.
  Опубликовано: (2013)
• Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme
  по: Giannini, Caterina, et al.
  Опубликовано: (2005)